Document Detail

Reoperative sternotomy is associated with increased mortality after heart transplantation.
MedLine Citation:
PMID:  22959569     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Although several studies have examined factors affecting survival after orthotopic heart transplantation (OHT), few have evaluated the impact of reoperative sternotomy. We undertook this study to examine the incidence and impact of repeat sternotomies on OHT outcomes.
METHODS: We conducted a retrospective review of all adult OHT from 2 institutions. Primary stratification was by the number of prior sternotomies. The primary outcome was survival. Secondary outcomes included blood product utilization and commonly encountered postoperative complications. Multivariable Cox proportional hazards regression models examined mortality while linear regression models examined blood utilization.
RESULTS: From January 1995 to October 2011, 631 OHT were performed. Of these, 25 (4.0%) were redo OHT and 182 (28.8%) were bridged to transplant with a ventricular assist device; 356 (56.4%) had undergone at least 1 prior sternotomy. On unadjusted analysis, reoperative sternotomy was associated with decreased 90-day (98.5% vs 90.2%, p<0.001), 1-year (93.1% vs 79.6%, p<0.001), and 5-year (80.4% vs 70.1%, p=0.002) survival. This difference persisted on multivariable analysis at 90 days (hazard ratio [HR] 2.99, p=0.01), 1 year (HR 2.98, p=0.002), and 5 years (HR 1.62, p=0.049). The impact of an increasing number of prior sternotomies was negligible. On multivariable analysis, an increasing number of prior sternotomies was associated with increased intraoperative blood product utilization. Increasing blood utilization was associated with decreased 90-day, 1-year, and 5-year survival.
CONCLUSIONS: Reoperative sternotomy is associated with increased mortality and blood utilization after OHT. Patients with more than 1 prior sternotomy do not experience additional increased mortality. Carefully selected patients with multiple prior sternotomies have decreased but acceptable outcomes.
Timothy J George; Claude A Beaty; Gregory A Ewald; Stuart D Russell; Ashish S Shah; John V Conte; Glenn J Whitman; Scott C Silvestry
Related Documents :
15671089 - Short-term effects of growth hormone (gh) treatment or deprivation on cardiovascular ri...
9413809 - Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopath...
8486199 - Long-acting injectable bromocriptine (parlodel lar) in the chronic treatment of prolact...
23639499 - Cardiovascular fitness and mortality after contemporary cardiac rehabilitation.
1563079 - A prospective examination of octreotide-induced gall-bladder changes in acromegaly.
745579 - Medical management of acromegaly with bromocriptine. effects of continuous treatment fo...
23609559 - Use of reflectance spectrophotometry to predict the response of port wine stains to pul...
10234999 - The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage.
25333379 - Bioelectrical impedance vector analysis and clinical outcomes in patients with acute he...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural     Date:  2012-09-07
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  94     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-26     Completed Date:  2013-01-29     Revised Date:  2014-06-04    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  2025-32     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Loss, Surgical / mortality*,  statistics & numerical data
Follow-Up Studies
Heart Failure / mortality,  surgery*
Heart Transplantation / mortality*
Kaplan-Meier Estimate
Middle Aged
Reoperation / adverse effects*,  mortality
Retrospective Studies
Risk Assessment / methods*
Sternotomy / adverse effects*,  mortality
Time Factors
Treatment Outcome
United States / epidemiology
Young Adult
Grant Support
T32 2T32DK007713-12/DK/NIDDK NIH HHS; T32 CA126607/CA/NCI NIH HHS; T32 DK007713/DK/NIDDK NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Costs of Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.
Next Document:  Initial Experience With the Use of Biological Implants for Soft Tissue and Chest Wall Reconstruction...